Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging therapeutics and evolving assessment criteria for intracranial metastases in patients with oncogene-driven non-small-cell lung cancer
Kelsey Pan, Kyle Concannon, Jing Li, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 10, pp. 716-732
Closed Access | Times Cited: 22

Showing 22 citing articles:

Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 21
Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade
Minjie Fu, Jiaxu Zhao, Licheng Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1882-1897.e7
Closed Access | Times Cited: 10
Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial
Yanjun Xu, Kaiyan Chen, Yujin Xu, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 1, pp. 74-84
Closed Access
Roles of SPOCK1 in the Formation Mechanisms and Treatment of Non-Small-Cell Lung Cancer and Brain Metastases from Lung Cancer
Xuebing Zhang, Xia Zhang, Hang Yin, et al.
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 35-47
Open Access
GRHL2-HER3 and E-cadherin mediate EGFR-bypass drug resistance in lung cancer cells
Fumiya Ito, Wakiko Iwata, Yoshihiro Adachi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Metastatic SQSTM1-NTRK1 fused non-small-cell lung cancer treated with larotrectinib and stereotactic radiosurgery resulting in durable complete response: a case report
Colton Betts, A. Kassardjian, Arya Amini
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care
Alireza Mansouri, Ahmad Ozair, Debarati Bhanja, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access
The clinicopathologic and prognostic value of CD44 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis
Elmira Alaei, Najma Farahani, Sima Orouei, et al.
Molecular and Cellular Probes (2025), pp. 102028-102028
Open Access
Establishment and Characterization of a Brain Parenchymal Metastatic Cell Line AlmoR1 Derived From an NSCLC Patient With EGFR‐TKI Resistance
Jingyi Wu, Xinglong Wu, Jing Wang, et al.
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access
Intersection between lung cancer and neuroscience: opportunities and challenges
Xiang Xiao, Lingli Huang, Ming Li, et al.
Cancer Letters (2025), pp. 217701-217701
Closed Access
Biological mechanisms and immunotherapy of brain metastases in non-small cell lung cancer
Shih Sheng Jiang, Fengzhu Guo, Lin Li
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189320-189320
Closed Access
Engineered lung cell targeting and SLC7A11 siRNA expressing bacterial extracellular vesicles impair the progression of none‐small cell lung cancer
Xiaodan Wan, Xueliang Zhou, Jinlong Liu, et al.
Bioengineering & Translational Medicine (2025)
Open Access
Immunotherapy revolutionizing brain metastatic cancer treatment: personalized strategies for transformative outcomes
Ting Li, Shichen Sun, Yubing Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Leptomeningeal metastatic disease: new frontiers and future directions
Ahmad Ozair, Hannah Wilding, Debarati Bhanja, et al.
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 2
Fifteen-Fraction Radiosurgery Followed by Reduced-Dose Whole-Brain Irradiation With a Total Biologically Effective Dose of >90-100 Gy for a Locally Invasive Brain Metastasis From Lung Adenocarcinoma With a High Dissemination Potential
Kazuhiro Ohtakara, Fumiharu Ohka, Kuniaki Tanahashi, et al.
Cureus (2023)
Open Access | Times Cited: 5
Brain metastases in clinical trial participants with KRAS-mutated advanced non-small cell lung cancer receiving docetaxel: Pooled data analysis
Jacob Aptekar, Rahul Jain, Beata Korytowsky, et al.
Lung Cancer (2024) Vol. 193, pp. 107854-107854
Open Access | Times Cited: 1
Efficacy and safety of combining anti-angiogenic therapy, radiotherapy, and PD-1 inhibitors in patients with driver gene-negative non-small cell lung cancer brain metastases: a retrospective study
Xianwen Zhang, Qian Sun, Rujun Chen, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
TClC effectively suppresses the growth and metastasis of NSCLC via polypharmacology
Jing Lu, Ying Zhang, Chunyan Yan, et al.
Bioactive Materials (2024) Vol. 45, pp. 567-583
Closed Access | Times Cited: 1
Determination of Pralsetinib in Human Plasma and Cerebrospinal Fluid for Therapeutic Drug Monitoring by Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS)
Zichen Zhao, Qianlun Pu, Tonglin Sun, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 11, pp. 867-877
Closed Access
Foxd3/SLC5A6 axis regulates apoptosis in LUAD cells by controlling mitochondrial biotin uptake
Chong Zheng, Wenxuan Hu, Danni Wu, et al.
Cellular Signalling (2024) Vol. 125, pp. 111473-111473
Closed Access
PEARL: A multicenter phase 2 study of lorlatinib in patients with ALK-rearranged NSCLC and central nervous system disease
Chang Lu, Hong-Hong Yan, Chanyuan Zhang, et al.
Clinical Lung Cancer (2024)
Closed Access
Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with leptomeningeal metastases harboring targetable mutations
Xiaoyu Ji, Rongrong Jiang, Tao Liu, et al.
Translational Lung Cancer Research (2023)
Open Access
Page 1

Scroll to top